CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands |
12 Months Ended |
Dec. 31, 2021 |
Dec. 31, 2020 |
| Income Statement [Abstract] |
|
|
| Product sales, net |
$ 8,244
|
$ 446
|
| Operating expenses: |
|
|
| Cost of goods sold |
4,055
|
468
|
| Research and development |
33,129
|
17,050
|
| Selling and marketing |
113,152
|
56,467
|
| General and administrative |
24,709
|
30,085
|
| Total operating expenses |
175,045
|
104,070
|
| Loss from operations |
(166,801)
|
(103,624)
|
| Other income (expense): |
|
|
| Interest income |
15
|
169
|
| Other expense |
(4,732)
|
(2,082)
|
| Loss on issuance of financial instruments |
0
|
(64,049)
|
| Change in fair value of financial instruments |
(33,657)
|
27,281
|
| Total other expense, net |
(38,374)
|
(38,681)
|
| Loss before income tax |
(205,175)
|
(142,305)
|
| Income tax expense |
(17)
|
(4)
|
| Net loss |
(205,192)
|
(142,309)
|
| Series B-1 and B-2 convertible preferred stock deemed dividends |
(1,047)
|
0
|
| Net loss attributable to common stockholders, basic |
(206,239)
|
(142,309)
|
| Net loss attributable to common stockholders, diluted |
$ (206,239)
|
$ (142,309)
|
| Net loss per share attributable to common stockholders, basic (in dollars per share) |
$ (1.58)
|
$ (2.12)
|
| Net loss per share attributable to common stockholders, diluted (in dollars per share) |
$ (1.58)
|
$ (2.12)
|
| Weighted-average shares used to compute net loss per share, basic (in shares) |
130,908,794
|
67,157,278
|
| Weighted-average shares used to compute net loss per share, diluted (in shares) |
130,908,794
|
67,157,278
|